Literature DB >> 18322201

Structural and biological basis of CTL escape in coronavirus-infected mice.

Noah S Butler1, Alex Theodossis, Andrew I Webb, Michelle A Dunstone, Roza Nastovska, Sri Harsha Ramarathinam, Jamie Rossjohn, Anthony W Purcell, Stanley Perlman.   

Abstract

Cytotoxic T lymphocyte escape occurs in many human infections, as well as mice infected with the JHM strain of mouse hepatitis virus, which exhibit CTL escape variants with mutations in a single epitope from the spike glycoprotein (S510). In all CTL epitopes prone to escape, only a subset of all potential variants is generally detected, even though many of the changes that are not selected would result in evasion of the T cell response. It is postulated that these unselected mutations significantly impair virus fitness. To define more precisely the basis for this preferential selection, we combine x-ray crystallographic studies of the MHC class I (D(b))/S510 complexes with viral reverse genetics to identify a prominent TCR contact residue (tryptophan at position 4) prone to escape mutations. The data show that a mutation that is commonly detected in chronically infected mice (tryptophan to arginine) potently disrupts the topology of the complex, explaining its selection. However, other mutations at this residue, which also abrogate the CTL response, are never selected in vivo even though they do not compromise virus fitness in acutely infected animals or induce a significant de novo CTL response. Thus, while structural analyses of the S510/D(b) complex provide a strong basis for why some CTL escape variants are selected, our results also show that factors other than effects on virus fitness limit the diversification of CD8 T cell epitopes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322201     DOI: 10.4049/jimmunol.180.6.3926

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.

Authors:  Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

2.  Crystal structure of the giant panda MHC class I complex: First insights into the viral peptide presentation profile in the bear family.

Authors:  Hongyu Yuan; Lizhen Ma; Lijie Zhang; Xiaoying Li; Chun Xia
Journal:  Protein Sci       Date:  2020-10-30       Impact factor: 6.725

3.  Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes.

Authors:  Jonathan A Trujillo; Stephanie Gras; Kelly-Anne Twist; Nathan P Croft; Rudragouda Channappanavar; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman
Journal:  J Immunol       Date:  2014-05-02       Impact factor: 5.422

4.  The cellular redox environment alters antigen presentation.

Authors:  Jonathan A Trujillo; Nathan P Croft; Nadine L Dudek; Rudragouda Channappanavar; Alex Theodossis; Andrew I Webb; Michelle A Dunstone; Patricia T Illing; Noah S Butler; Craig Fett; David C Tscharke; Jamie Rossjohn; Stanley Perlman; Anthony W Purcell
Journal:  J Biol Chem       Date:  2014-08-18       Impact factor: 5.157

5.  Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

Authors:  Mahesh Yadav; Suchit Jhunjhunwala; Qui T Phung; Patrick Lupardus; Joshua Tanguay; Stephanie Bumbaca; Christian Franci; Tommy K Cheung; Jens Fritsche; Toni Weinschenk; Zora Modrusan; Ira Mellman; Jennie R Lill; Lélia Delamarre
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

6.  Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.

Authors:  Sophie A Valkenburg; Stephanie Gras; Carole Guillonneau; Nicole L La Gruta; Paul G Thomas; Anthony W Purcell; Jamie Rossjohn; Peter C Doherty; Stephen J Turner; Katherine Kedzierska
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

7.  Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination.

Authors:  Adil Doganay Duru; Renhua Sun; Eva B Allerbring; Jesseka Chadderton; Nadir Kadri; Xiao Han; Kaliroi Peqini; Hannes Uchtenhagen; Chaithanya Madhurantakam; Sara Pellegrino; Tatyana Sandalova; Per-Åke Nygren; Stephen J Turner; Adnane Achour
Journal:  PLoS Pathog       Date:  2020-05-04       Impact factor: 6.823

8.  Mapping the drivers of within-host pathogen evolution using massive data sets.

Authors:  Duncan S Palmer; Isaac Turner; Sarah Fidler; John Frater; Dominique Goedhals; Philip Goulder; Kuan-Hsiang Gary Huang; Annette Oxenius; Rodney Phillips; Roger Shapiro; Cloete van Vuuren; Angela R McLean; Gil McVean
Journal:  Nat Commun       Date:  2019-07-09       Impact factor: 14.919

9.  Prevention of cytotoxic T cell escape using a heteroclitic subdominant viral T cell determinant.

Authors:  Noah S Butler; Alex Theodossis; Andrew I Webb; Roza Nastovska; Sri Harsha Ramarathinam; Michelle A Dunstone; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman
Journal:  PLoS Pathog       Date:  2008-10-24       Impact factor: 6.823

Review 10.  Enhancing Human Immunodeficiency Virus-Specific CD8(+) T Cell Responses with Heteroclitic Peptides.

Authors:  Adeolu Oyemade Adegoke; Michael David Grant
Journal:  Front Immunol       Date:  2015-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.